STOCK TITAN

IONS (Nasdaq: IONS) insider notice: 37,277 shares from option exercises

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

IONS filed a Form 144 notifying proposed sales of Common Stock. The notice lists two option-exercise related lots of 4,675 and 32,602 shares scheduled on 03/10/2026 to be sold for cash. The filing also reports a prior sale of 1,823 shares on 01/16/2026 for $138,963 by Kyle Jenne.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IONS' Form 144 disclose about upcoming share sales?

The filing discloses two option-exercise share lots of 4,675 and 32,602 shares scheduled on 03/10/2026 to be sold for cash. It lists these as issuer-related option exercises.

Who sold shares recently according to the IONS Form 144?

The filing shows that Kyle Jenne sold 1,823 shares on 01/16/2026 for $138,963. This sale is reported under "Securities Sold During The Past 3 Months."

Are the proposed sales in the Form 144 linked to option exercises?

Yes. The filing explicitly lists the two scheduled lots as resulting from Option Exercise with proceeds listed as Cash, indicating shares are to be sold following exercise events on 03/10/2026.

Does the Form 144 state how the shares will be sold (method)?

The excerpt specifies the shares arise from Option Exercise and the consideration as Cash, but it does not describe sale methods like block trades or brokerage transactions in the provided excerpt.

How many total shares are listed for the proposed sale in this filing?

The filing lists two lots totalling 37,277 shares (4,675 and 32,602) scheduled on 03/10/2026. This total is the sum of the two explicitly listed option-exercise lots.
Ionis Pharmaceuticals

NASDAQ:IONS

View IONS Stock Overview

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

12.45B
160.38M
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD